Image 5_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg

Image 5_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg

Introduction<p>Oropharyngeal squamous cell carcinoma (OPC) associated with high-risk human papillomavirus (HPV), particularly HPV-16, generally shows favorable outcomes yet paradoxically exhibits a high incidence of early lymphatic metastasis. The immune mechanisms underlying this phenomenon r...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Naohiro Wakisaka (407153) (author)
Andere auteurs:	Makiko Moriyama-Kita (833101) (author), Satoru Kondo (407152) (author), Eiji Kobayashi (107710) (author), Takayoshi Ueno (457816) (author), Yosuke Nakanishi (407151) (author), Kazuhira Endo (407155) (author), Hisashi Sugimoto (2146888) (author), Tomokazu Yoshizaki (407160) (author)
Gepubliceerd in:	2025
Onderwerpen:	Oncology and Carcinogenesis not elsewhere classified HPV-positive oropharyngeal cancer palatine tonsil spatial transcriptomics tumor immune microenvironment Th2 immunity lymphatic metastasis eosinophils and mast cells estrogen signaling
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Image 4_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
door: Naohiro Wakisaka (407153)
Gepubliceerd in: (2025)

Image 2_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
door: Naohiro Wakisaka (407153)
Gepubliceerd in: (2025)

Image 3_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
door: Naohiro Wakisaka (407153)
Gepubliceerd in: (2025)

Image 1_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
door: Naohiro Wakisaka (407153)
Gepubliceerd in: (2025)

Table 1_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.xlsx
door: Naohiro Wakisaka (407153)
Gepubliceerd in: (2025)

Table 1_Immune responses in pulmonary sarcoidosis following COVID-19.docx
door: Anna Starshinova (22571846)
Gepubliceerd in: (2025)

Substrate recognition diversity and transport dynamics of ABCC1
door: Pu Gao (14074898)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
door: Glenn J. Hanna (15036909)
Gepubliceerd in: (2025)

Data Sheet 10_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 9_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 8_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 6_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 7_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 5_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 4_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 3_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 2_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Data Sheet 1_LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis.zip
door: Huiping Fan (13921872)
Gepubliceerd in: (2025)

Microbiome Mediated Immune Crosstalk on the Gut-Thyroid Axis in Autoimmune Thyroid Disease
door: Mubeen Hussein Arawker (12965954)
Gepubliceerd in: (2025)

Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.
door: Seyed Reza Mousavi (13223324)
Gepubliceerd in: (2025)

Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.
door: Seyed Reza Mousavi (13223324)
Gepubliceerd in: (2025)

Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].
door: Seyed Reza Mousavi (13223324)
Gepubliceerd in: (2025)

The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.
door: Seyed Reza Mousavi (13223324)
Gepubliceerd in: (2025)

Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.
door: Seyed Reza Mousavi (13223324)
Gepubliceerd in: (2025)

Survey of dysphagia protocol use (Carnaby et al., 2025)
door: Giselle D. Carnaby (22575401)
Gepubliceerd in: (2025)

Image 2_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
door: Yini Wang (410389)
Gepubliceerd in: (2025)

Image 1_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
door: Yini Wang (410389)
Gepubliceerd in: (2025)

Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.
door: Ricardo E. Correa Fierro (22676430)
Gepubliceerd in: (2025)

Table 1_Immune checkpoint inhibitor therapy in advanced cancer: clinical association of irAEs type, inflammatory markers and efficacy.docx
door: Mengying Qian (2541466)
Gepubliceerd in: (2025)

Table S2 from Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer
door: Taohua Yue (14963045)
Gepubliceerd in: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
door: Yu Chen (1234761)
Gepubliceerd in: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
door: Yu Chen (1234761)
Gepubliceerd in: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
door: Yu Chen (1234761)
Gepubliceerd in: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
door: Yu Chen (1234761)
Gepubliceerd in: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
door: Isha Mondal (16721699)
Gepubliceerd in: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
door: Kankan Cao (16437263)
Gepubliceerd in: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_36q9dp3en4m1t0ag7m0fa4bl1h